+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Transcutaneous Electrical Nerve Stimulation Market by Surgery Procedures, Product, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995141
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Transcutaneous Electrical Nerve Stimulation Market grew from USD 336.69 million in 2023 to USD 348.82 million in 2024. It is expected to continue growing at a CAGR of 3.69%, reaching USD 434.08 million by 2030.

Transcutaneous Electrical Nerve Stimulation (TENS) involves the use of electrical impulses to interfere with pain signals in the body. Employed primarily for pain management, TENS therapy caters to conditions like arthritis, fibromyalgia, and postoperative pain, providing a non-invasive alternative to pain relief drugs. The expanding consumer inclination toward portable, home-use medical devices is propelling the TENS market's growth, driven by the rising prevalence of chronic pain conditions and an aging population. Technological advancements, such as wireless connectivity and innovative electrode designs, are significantly influencing market dynamics. An increasing focus on personalized treatment solutions presents potential growth opportunities for market players. However, limitations such as the efficacy of TENS varying among individuals, lack of supportive medical reimbursements, and regulatory hurdles pose challenges to widespread adoption. Market growth is further hindered by a limited understanding of TENS applications in broader medical communities and the potential side effects of inappropriate use. Research endeavors in improving device efficiency, leveraging artificial intelligence for optimized pain management, and expanding TENS applications beyond pain relief can foster innovation. Opportunities lie in broader consumer education about TENS benefits and integrating telemedicine with portable devices for remote therapy monitoring. The competitive nature of the TENS market underscores an urgent need for product differentiation and strategic partnerships to enhance distribution networks. Encouraging clinical trials to ascertain broader efficacy and improving user-friendly interfaces for aged populations can also address existing barriers. Companies that successfully navigate compliance landscapes while prioritizing patient-centric innovations are positioned to capitalize effectively. By advancing research into multimodal pain management and focusing on ergonomic device designs, businesses can secure a competitive edge and capture untapped market segments, ensuring robust growth in a burgeoning healthcare sector.

Understanding Market Dynamics in the Transcutaneous Electrical Nerve Stimulation Market

The Transcutaneous Electrical Nerve Stimulation Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising popularity of muscle stimulators among physiotherapists
    • Increasing emphasis on pain management therapies in sports medicine
    • Rising prevalence of musculoskeletal disorders among citizens
  • Market Restraints
    • Increased cost of nerve stimulation therapy
  • Market Opportunities
    • Rising technological advancements and modernization in the machinery used in healthcare sector
    • Rising research and development activities in the healthcare sector
  • Market Challenges
    • Lack of skilled or trained physicians

Exploring Porter’s Five Forces for the Transcutaneous Electrical Nerve Stimulation Market

Porter’s Five Forces framework further strengthens the insights of the Transcutaneous Electrical Nerve Stimulation Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Transcutaneous Electrical Nerve Stimulation Market

External macro-environmental factors deeply influence the performance of the Transcutaneous Electrical Nerve Stimulation Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Transcutaneous Electrical Nerve Stimulation Market

The Transcutaneous Electrical Nerve Stimulation Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Transcutaneous Electrical Nerve Stimulation Market

The Transcutaneous Electrical Nerve Stimulation Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Transcutaneous Electrical Nerve Stimulation Market

The Transcutaneous Electrical Nerve Stimulation Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transcutaneous Electrical Nerve Stimulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, BioMedical Life Systems, Bioness, Inc., Boston Scientific Corporation, Chirag Electronics Private Limited, S.m.r.a, Cochlear Ltd, Cogentix Medical, Inc., Cyberonics, Inc., DJO LLC., ElectroCore, Inc., EMS Physio Ltd, Medtronic plc, NeuroMetrix, Inc., NeuroPace Inc, Nevro Corp, OMRON Corporation, R-slimming Medical Systems, Uroplasty, Inc., and Zynex Medical.

Market Segmentation & Coverage

This research report categorizes the Transcutaneous Electrical Nerve Stimulation Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Surgery Procedures
    • Direct Nerve Repair
    • Nerve Grafting
    • Stem Cell Therapy
  • Product
    • Desktop
    • Portable
  • End User
    • Clinics
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising popularity of muscle stimulators among physiotherapists
5.1.1.2. Increasing emphasis on pain management therapies in sports medicine
5.1.1.3. Rising prevalence of musculoskeletal disorders among citizens
5.1.2. Restraints
5.1.2.1. Increased cost of nerve stimulation therapy
5.1.3. Opportunities
5.1.3.1. Rising technological advancements and modernization in the machinery used in healthcare sector
5.1.3.2. Rising research and development activities in the healthcare sector
5.1.4. Challenges
5.1.4.1. Lack of skilled or trained physicians
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Transcutaneous Electrical Nerve Stimulation Market, by Surgery Procedures
6.1. Introduction
6.2. Direct Nerve Repair
6.3. Nerve Grafting
6.4. Stem Cell Therapy
7. Transcutaneous Electrical Nerve Stimulation Market, by Product
7.1. Introduction
7.2. Desktop
7.3. Portable
8. Transcutaneous Electrical Nerve Stimulation Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospital
9. Americas Transcutaneous Electrical Nerve Stimulation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET RESEARCH PROCESS
FIGURE 2. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET DYNAMICS
TABLE 7. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 28. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. CANADA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 31. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. MEXICO TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 45. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CHINA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 48. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. INDIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 54. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. JAPAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 72. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. THAILAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 82. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. DENMARK TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 85. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. EGYPT TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 88. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. FINLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 91. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. FRANCE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 94. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. GERMANY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 100. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ITALY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 109. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. NORWAY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 112. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. POLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 115. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. QATAR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 127. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SPAIN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 136. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. TURKEY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Transcutaneous Electrical Nerve Stimulation Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • BioMedical Life Systems
  • Bioness, Inc.
  • Boston Scientific Corporation
  • Chirag Electronics Private Limited, S.m.r.a
  • Cochlear Ltd
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO LLC.
  • ElectroCore, Inc.
  • EMS Physio Ltd
  • Medtronic plc
  • NeuroMetrix, Inc.
  • NeuroPace Inc
  • Nevro Corp
  • OMRON Corporation
  • R-slimming Medical Systems
  • Uroplasty, Inc.
  • Zynex Medical

Methodology

Loading
LOADING...

Table Information